Clinical Trials Available
DCVax®-L for Newly Diagnosed Brain Cancer
» Clinical Sites:
Los Angeles, UCLA Medical Center
Linda Liau, MD
Phone: 310-794-5664
E-mail: lliau@mednet.ucla.edu
Detroit, Henry Ford Health System
Tom Mikkelsen, MD
Phone: 313-916-8641
E-mail: nstom@neuro.hfh.edu
New Jersey, Overlook Hospital
Michael L. Gruber, MD
Phone: 908-522-5914
E-mail: michael.gruber@nyumc.org
New York, NYU Cancer Institute
Michael L. Gruber, MD
Phone: 212-731-5577
E-mail: michael.gruber@nyumc.org
University of Cincinnati
Margie Gerena-Lewis, MD
Phone: 513-584-6178
E-mail: lewism2@ucmail.uc.edu
University of Illinois at Chicago
John Villano, MD
Phone: 312-996-6768
E-mail: jvillano@uic.edu
Virginia Piper Cancer Institute
John Trusheim, MD
Phone: 612-863-9215
E-mail: Nilanjana.banerji@allina.com
University of Michigan
Jason Heth, MD
Phone: 734-615-4486
E-mail: jheth@umich.edu
University of Hospitals of Cleveland
Andrew E. Sloan, MD
Phone: 216-844-6054
E-mail: andrew.sloan@uhhospitals.org
Baylor Research Institute
Karen Fink, MD, PhD
Phone: 214-820-8690
E-mail: karenfin@baylorhealth.edu
Moffitt Cancer Center
Steven Brem, MD
Phone: 813-979-3063
E-mail: brem@moffitt.usf.edu
University of Rochester
Kevin A. Walter, MD
Phone: 585-276-3581
E-mail: Kevin_Walter@URMC.Rochester.Edu
|
